When the New York Appellate Division, First Department, decided Beauchamp v. New York City Transit Authority on September 17, 2026, it did something unusual for a high-stakes damages reduction: it explained its work in enough detail to give plaintiff practitioners a genuine roadmap for the next catastrophic injury case. The opinion does not change the governing standard, but it applies CPLR 5501(c) with a granularity that makes the materiality of damages-record gaps visible in real time.
The Facts
On March 6, 2017, Aurora Beauchamp, then 62, was crossing a Manhattan street in a marked crosswalk when a New York City Transit Authority bus struck her and dragged her beneath the vehicle. She was pinned for approximately 20 minutes while conscious, believing she would die. The Transit Authority admitted liability before trial, so the only contested question was damages.
Beauchamp's injuries were catastrophic: a torn lumbosacral plexus affecting her left leg, multiple pelvic fractures, 19 broken ribs, a ruptured bladder, degloving injuries requiring twice-daily wound care that never fully healed, complex regional pain syndrome with chronic pain rated 8 to 9 out of 10, and post-traumatic stress disorder with nightmares and suicidal ideation. She was hospitalized for 43 days in acute care and 112 days in rehabilitation.
The jury awarded $72.5 million: $25 million for past pain and suffering, $32 million for future pain and suffering, $8.5 million for future medical expenses, $3 million for her husband's past loss of services, and $4 million for her husband's future loss of services. The First Department reduced the total to approximately $47.8 million, leaving the liability verdict intact.
The CPLR 5501(c) Standard and What It Actually Requires
Under CPLR 5501(c), an appellate court can reduce a damages award that deviates materially from what would be reasonable compensation. The standard does not permit second-guessing the jury's assessment of credibility, and it does not reduce verdicts simply because they are large. What it does do is require that an appellate court finding of material deviation be supportable by identifying either a lack of evidentiary basis for the amount awarded or a comparison to analogous cases that shows the award is outside the range of reasonable compensation for comparable injuries.
The First Department applied that standard in detail. For past pain and suffering, the court reduced the $25 million award to $20 million, finding that while the injuries were severe, the record supported a reduction to bring the award within the range established by comparable catastrophic injury cases in New York. The court cited the absence of prior cases with comparable injuries producing a $25 million past pain and suffering component as support for the reduction.
For future pain and suffering, the reduction was more substantial: from $32 million to $17 million. The court noted the plaintiff's age at the time of trial and the actuarial life expectancy, which effectively capped the duration of future suffering. Plaintiff's counsel had presented a per diem argument for future suffering, and while the First Department did not reject that approach, it found the rate too high to be supported by the evidence when applied across the plaintiff's remaining life expectancy.
The Future Medical Evidence Problem
The future medical expenses reduction offers the most actionable lesson. The jury awarded $8.5 million; the court reduced it to $8.24 million, a relatively modest cut, but the court explained which components survived and which did not in terms that are instructive.
The court applied a standard that should be familiar but is often underweighted in life care planning: each line item of future medical expenses must rest on a specific treatment recommendation, a medical reason for that treatment, and a supported cost. Items that survived were those tied to the documented treatment trajectory: ongoing wound care, physical therapy, the existing medication regimen, and anticipated orthopedic and neurological follow-up. Items that were reduced or eliminated were those that lacked a specific medical recommendation in the record. The court specifically identified proposed future spinal cord stimulators as speculative, noting that the treating neurologist had testified they were not medically advisable for this patient given her injury profile.
This is the detail that plaintiff practitioners should take back to their life care planners. A life care plan that packages a complete array of possible treatments for the injury type, without tying each item to this patient's documented needs and this treating physician's actual recommendations, will be vulnerable to precisely this reduction. The life care planner and the treating team need to be integrated; the plan needs to be defensible line by line, not just as a global number.
Consortium and Services Damages
The husband's past loss of services was reduced from $3 million to $1.5 million, and his future loss of services was reduced from $4 million to $1.1 million. The court found these awards excessive relative to the supporting testimony about the specific services the husband had provided and was expected to provide. The reduction signals that consortium and household services damages, even in a catastrophic case, need to be grounded in specific testimony about what the injured spouse can no longer do and what the uninjured spouse has taken on, not simply in the severity of the underlying injuries.
For case teams building consortium claims, the lesson is longitudinal documentation: a record of household task allocation before the injury compared to after, testimony from the uninjured spouse about specific tasks that shifted to them, and if the economic component is significant, a forensic economist's valuation of the replaced household services. Aggregate awards based on the judge or jury doing their own arithmetic from general testimony about a bad marriage outcome will be vulnerable to the same reduction the Beauchamps experienced on the consortium component.
Practice Implications
The Beauchamp opinion is a useful calibration for catastrophic injury damage cases in New York. It confirms that nine-figure jury verdicts in cases with severe but survivable injuries will face reduction under CPLR 5501(c), and it tells plaintiff counsel exactly what the reduction mechanism looks at: comparator cases, life care plan specificity, and the link between the specific plaintiff's medical history and the specific treatments claimed.
For firms outside New York, the analogous principle applies in any jurisdiction with a remittitur standard. The standard question is always whether the evidence supports the specific amount, not whether the injuries are severe. Severe injuries with a vague or over-inclusive damages record are still vulnerable to reduction; severe injuries with a specific, witness-anchored, record-tied damages case have the best chance of surviving appellate scrutiny.
For more on damages record construction in catastrophic injury cases, see our case law and settlements coverage. The mechanics of life care planning for comp and PI cases is addressed in the wrongful death section, which covers expert damages modeling in detail.